The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III, randomized, double-blind, multicenter, placebo (P)-controlled trial of rilotumumab (R) plus epirubicin, cisplatin and capecitabine (ECX) as first-line therapy in patients (pts) with advanced MET-positive (pos) gastric or gastroesophageal junction (G/GEJ) cancer: RILOMET-1 study.
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)
 
Niall C. Tebbutt
Consulting or Advisory Role - Amgen
Research Funding - Amgen
 
Irina Davidenko
No Relationships to Disclose
 
André M. Murad
Travel, Accommodations, Expenses - Roche
 
Salah-Eddin Al-Batran
Honoraria - Lilly; Roche Pharma AG
Consulting or Advisory Role - Lilly; Roche Pharma AG
Research Funding - Celgene; Novartis; Roche Pharma AG; Sanofi
 
David H. Ilson
Consulting or Advisory Role - Amgen; Lilly/ImClone; Roche/Genentech
Speakers' Bureau - Genentech/Roche
Research Funding - Amgen; Bayer; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; Genentech/Roche
 
Sergei Tjulandin
Speakers' Bureau - AstraZeneca; Eisai; Pfizer; Sanofi
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Boehringer Ingelheim; Merck Serono
 
Evgeny Gotovkin
No Relationships to Disclose
 
Boguslawa Karaszewska
No Relationships to Disclose
 
Igor Bondarenko
No Relationships to Disclose
 
Mohamedtaki Abdulaziz Tejani
No Relationships to Disclose
 
Anghel Adrian Udrea
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Teva
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Lilly; Teva
 
Mustapha Ali Tehfe
Consulting or Advisory Role - Amgen; Celgene; Lilly; Roche Pharma AG
 
Nigel Baker
Employment - Amgen
Leadership - Amgen
Stock and Other Ownership Interests - Amgen
 
Kelly Smith Oliner
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Yilong Zhang
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Tien Hoang
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Roger Sidhu
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Daniel Virgil Thomas Catenacci
Honoraria - Amgen; Foundation Medicine; Genentech/Roche; Genmab; Lilly; OncoPlex Diagnostics; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Genentech/Roche; OncoPlex Diagnostics
Speakers' Bureau - Foundation Medicine; Lilly; OncoPlex Diagnostics
Research Funding - Amgen; Genentech; OncoPlex Diagnostics